We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page.
Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site.
Oslo 22 March 2021 – Observe Medical ASA (OSE: OBSRV), today announces that Observe Medical Group has received a follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market. The follow-up order represents a value of 4.2 mSEK, with planned delivery of the products during Q3 this year.…
Read moreOslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome…
Read moreObserve Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/…
Read moreQuarterly Presentation – Q4
Annual Report
Quarterly Presentation - Q1
Annual General Meeting
Half-yearly Report
Quarterly Presentation - Q3
Last updated 6 April 2021
| Name | Number of shares | % of top 20 | % of total | Country | |
|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 4,222,727 | 25.18% | 21.54% | Norway |
| 2 | INGERØ REITEN INV. COMPANY AS | 3,939,394 | 23.49% | 20.09% | Norway |
| 3 | RO, LARS | 1,500,051 | 8.95% | 7.65% | NORWAY |
| 4 | UBS SWITZERLAND AG | 1,417,522 | 8.45% | 7.23% | SWITZERLAND |
| 5 | ARTAL AS | 1,007,707 | 6.01% | 5.14% | Norway |
| 6 | NORDA ASA | 664,570 | 3.96% | 3.39% | NORWAY |
| 7 | ALPINE CAPITAL AS | 652,279 | 3.89% | 3.33% | Norway |
| 8 | Soleglad Invest AS | 586,668 | 3.50% | 2.99% | NORWAY |
| 9 | TRANBERGKOLLEN INVEST AS | 500,000 | 2.98% | 2.55% | Norway |
| 10 | LEIKERANE AS | 373,439 | 2.23% | 1.90% | Norway |
| 11 | LAPAS AS | 348,326 | 2.08% | 1.78% | Norway |
| 12 | GINNY INVEST AS | 255,030 | 1.52% | 1.30% | NORWAY |
| 13 | PHILIP HOLDING AS | 245,000 | 1.46% | 1.25% | NORWAY |
| 14 | KRAEBER VERWALTUNG GMBH | 214,850 | 1.28% | 1.10% | GERMANY |
| 15 | MP PENSJON PK | 187,684 | 1.12% | 0.96% | NORWAY |
| 16 | CAM AS | 181,000 | 1.08% | 0.92% | NORWAY |
| 17 | NORDNET BANK AB | 137,542 | 0.82% | 0.70% | SWEDEN |
| 18 | ABC INVEST AS | 120,000 | 0.72% | 0.61% | NORWAY |
| 19 | PETTERSEN, GUNERIUS | 109,313 | 0.65% | 0.56% | NORWAY |
| 20 | EILERAAS, KARL ANSKAR | 104,490 | 0.62% | 0.53% | Norway |
| Total numBer owned by top 20 | 16,767,592 | 100.00% | 85.53% | ||
| Total number of shares | 19,605,457 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
19 605 457
NOK 0.26
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com